Infection in solid-organ transplant recipients

JA Fishman - New England Journal of Medicine, 2007 - Mass Medical Soc
Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections …

Antiviral drugs for viruses other than human immunodeficiency virus

RR Razonable - Mayo Clinic Proceedings, 2011 - Elsevier
Most viral diseases, with the exception of those caused by human immunodeficiency virus,
are self-limited illnesses that do not require specific antiviral therapy. The currently available …

Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice

RR Razonable, A Humar - Clinical transplantation, 2019 - Wiley Online Library
Cytomegalovirus (CMV) is one of the most common opportunistic infections that affect the
outcome of solid organ transplantation. This updated guideline from the American Society of …

Cytomegalovirus in solid organ transplantation

RR Razonable, A Humar - American journal of transplantation, 2013 - amjtransplant.org
Cytomegalovirus (CMV) is a ubiquitousherpes virus that infects the majority of humans (1).
The seroprevalence rates of CMV ranges from 30–97%(2, 3). Primary infection manifests as …

[图书][B] Diseases of the liver and biliary system

S Sherlock, J Dooley - 2002 - Wiley Online Library
Bilirubin metabolism, 205 Hepatic transport and conjugation of bilirubin, 205 Distribution of
jaundice in the tissues, 207 Factors determining the depth of jaundice, 207 Classification of …

[HTML][HTML] Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

C Paya, A Humar, ED Dominguez, K Washburn… - American Journal of …, 2004 - Elsevier
We compared the efficacy and safety of valganciclovir with those of oral ganciclovir in
preventing cytomegalovirus (CMV) disease in high-risk seronegative solid organ transplant …

Cytomegalovirus in solid organ transplant recipients

A Humar, D Snydman - American Journal of Transplantation, 2009 - amjtransplant.org
CMV infection is a major cause of morbidity in patients receiving solid organ transplants.
CMV is widely distributed in the general population with seroprevalence ranging from 30 to …

Pulmonary complications of solid organ and hematopoietic stem cell transplantation

RM Kotloff, VN Ahya, SW Crawford - American journal of respiratory …, 2004 - atsjournals.org
The ability to successfully transplant solid organs and hematopoietic stem cells represents
one of the landmark medical achievements of the twentieth century. Solid organ …

Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients

AC Kalil, J Levitsky, E Lyden, J Stoner… - Annals of internal …, 2005 - acpjournals.org
Background: Cytomegalovirus (CMV), the most common opportunistic viral infection in solid
organ transplant recipients, is associated with substantial morbidity and mortality. Purpose …

Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants

AP Limaye, L Corey, DM Koelle, CL Davis, M Boeckh - The Lancet, 2000 - thelancet.com
Background Concerns have been raised about emergence of ganciclovir resistance as a
result of the advent of both routine oral ganciclovir prophylaxis and highly potent immuno …